DNA Money - Feb. 2010

TROIKAA PHARMA SET TO GET US PATENT FOR DYNAPAR AQ

Troikaa Pharmaceuticals, a Gujarat-based fast growing healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ.

“Troikaa is shortly to get US patent for its Dyanapar AQ 1 ml injections, as proceedings at the USFDA have got over. We are just awaiting certificate and confirmation from them (USFDA),” managing director of Troikaa Pharmaceuticals Ketan patel said.